fashion -WSS

fashion

author：fashion 2025-10-04 10:47:52 - browse：2

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Eli Lilly’s Mounjaro succeeds in second weight

focus

WSS

WATCH: Why do our ears pop?

Congress may force more Covid

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Weight loss drugs aren’t covered by Obamacare. That may change

MD Anderson's Padmanee Sharma responds to research credit suit

focus

fashion

leisure time

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

The high cost of giving birth even with insurance

Living organ donors deserve priority status for transplants

Guidelines to prevent youth baseball injuries need more muscle

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Duchenne breakthrough therapy leaves behind pioneering families

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Sports medicine is finally prioritizing gender equality

MD Anderson's Padmanee Sharma responds to research credit suit

explore

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

WATCH: Why do our ears pop?

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Measles policy set amid Florida outbreak alarms vaccine proponents

Reporting on presidential health from Reagan to Trump and Biden

focus

knowledge

focus

entertainment